ANI
ANI Pharmaceuticals adds $300m revolving credit facility
ANI Pharmaceuticals finalized a $300 million credit agreement dated November 4, 2026, with JPMorgan Chase Bank as administrative agent and sole lead arranger.
ANI news
Latest 2 stories · newest Nov 5, 2026
ANI
ANI Pharmaceuticals amends 2022 stock incentive plan effective May 21, 2026
ANI Pharmaceuticals restated its 2022 Stock Incentive Plan for the third time, updating equity compensation terms and definitions. The amendment affects employee incentive structures and equity participation mechanisms for the company's workforce.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same ANI feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/ANI/newsSTART FREE